Brevan Howard Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$367K Buy
+27,683
New +$350K ﹤0.01% 1484
2026
Q2
– Sell
-35,893
Closed -$275K – 2495
2026
Q1
$275K Sell
35,893
-17,068
-32% -$130K ﹤0.01% 1681
2025
Q4
$515K Hold
52,961
– – 0.01% 1101
2025
Q3
$222K Sell
52,961
-5,281
-9% -$33.7K ﹤0.01% 1708
2025
Q2
$541K Buy
+58,242
New +$508K ﹤0.01% 1327
2024
Q3
– Sell
-39,170
Closed -$353K – 1382
2024
Q2
$353K Buy
39,170
+20,999
+116% +$146K ﹤0.01% 724
2024
Q1
$148K Buy
+18,171
New +$149K ﹤0.01% 849

Other funds holding REPL

Brevan Howard Capital Management's REPL Position: Q3 2026 in Review

Brevan Howard Capital Management opened a new position in Replimune Group (REPL) in Q3 2026: 27,683 shares worth $367K. The stake represents ﹤0.01% of the portfolio and ranks #1484 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in REPL as recently as Q1 2026.

Brevan Howard Capital Management first reported a position in REPL in Q1 2024 and has held it in 7 quarters since. The position peaked at $541K in Q2 2025. 210 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

  • Brevan Howard Capital Management held 27,683 shares of Replimune Group worth $367K as of Q3 2026.
  • Replimune Group was a new Brevan Howard Capital Management position in Q3 2026.
  • Replimune Group made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q3 2026, its #1484 holding.
  • Brevan Howard Capital Management first reported a position in Replimune Group in Q1 2024 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Replimune Group position peaked at $541K in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Brevan Howard Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.